SEC Form 4 · accession 0000903423-15-000108
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
GLAXOSMITHKLINE PLC
10% Owner
Period of report
Dec 10, 2014
Accepted (ET)
Feb 12, 2015 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 10, 2014 | S | 10,000 | $21.176 | D | 1,979,598 | I | By S.R. One Limited |
| Common StockF1 | Dec 11, 2014 | S | 12,500 | $21.2828 | D | 1,967,098 | I | By S.R. One Limited |
| Common StockF1 | Dec 12, 2014 | S | 7,500 | $21.2392 | D | 1,959,598 | I | By S.R. One Limited |
| Common StockF1 | Dec 17, 2014 | S | 8,000 | $21.00 | D | 1,951,598 | I | By S.R. One Limited |
| Common StockF1 | Dec 18, 2014 | S | 12,000 | $21.0113 | D | 1,939,598 | I | By S.R. One Limited |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline PLC (Reporting Person).